Livongo Stock
Livongo is empowering people with chronic conditions to live a better life.
Sign up today and learn more about Livongo Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Livongo Stock
Livongo is the leading consumer digital health company that empowers people with chronic conditions to live a better life. We have developed a completely new approach for diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights and support to make diabetes management easier. Our approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals. For more information visit: www.livongo.com.
Funding History
| November 2013 | $3.0M |
|---|---|
| September 2014 | $10.0M |
| April 2015 | $20.0M |
| April 2016 | $49.5M |
| March 2017 | $52.5M |
| April 2018 | $105M |
Management
Chief Executive Officer
Glen Tullman
Senior Vice President, Product
Amar Kendale
Senior Vice President, Marketing
Allan Ng
Chief Technology Officer
Dave Engberg
Chief Medical Officer
Dr. Jennifer Schneider
General Counsel
Brian Vandenberg
COO
Joe Carey
Chief Commercial Officer
Jim Pursley
Senior Vice President, Member Experience
Manny Hernandez
Senior Vice President, Member Advocacy
Lynn Crowe
Press
Wall Streets Journal - Jul, 25 2019
Two Health-Tech Companies Join Parade of IPOs With Strong DebutsForbes - Jul, 4 2019
Omada Health Raises $73M To Vie With Livongo In $50B Diabetes Coaching MarketForbes - Jun, 28 2019
Digital Health Company Livongo Files For An IPOForbes - Jun, 19 2019
Vida Health Raises $30 Million To Ramp Up Sales Of Personalized Chronic Disease CareWall Streets Journal - Mar, 7 2019
Digital-Health Startup Livongo Eyes 2019 IPOTechCrunch - Sep, 5 2018
Livongo Health expands under new offering with Abbott Labs- Jun, 23 2018
Livongo for Diabetes Achieves Sustained Positive 12-Month Outcomes for People with Type 2 Diabetes, New Research Finds- Jan, 24 2018
Livongo Launches HypertensionEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
